Long-Term Safety and Effectiveness of Upadacitinib or Adalimumab in Patients with Rheumatoid Arthritis: Results at 72 Weeks Fleischmann, R., Song, I., Enejosa, J., Mysler, E., Bessette, L., Durez, P., Ostor, A., Swierkot, J., Song, Y., Genovese, M. WILEY. 2020

View details for Web of Science ID 000587568500213